BRL-201 - BRL Medicine
cyclophosphamide - Generic mfg.
fludarabine IV - Generic mfg.
Actemra IV (tocilizumab) - Roche, JW Pharma
https://ash.confex.com/ash/2022/webprogram/Paper156137.html
 
Yongxian Hu, M.D., Ph.D.1,2,3,4*, Jiqin Zhang, PhD5,6*, Mingming Zhang2,3,4,7*, Wei Li, PhD6*, Wenjun Wu, MD1,3,4,8*, Jiazhen Cui1,3,4,8*, Guoqing Wei, MD1,2,3,4*, Bing Du, PhD5*, Mingyao Liu, PhD9* and He Huang1,2,3,4
 
Nov 4, 2022
 
Prev Next